Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY | 1698077 |
12 | 3 | CHEMISTRY, ORGANIC//JOURNAL OF HETEROCYCLIC CHEMISTRY//KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII | 138510 |
2577 | 2 | PYRROLOBENZODIAZEPINE//PYRROLE//HETEROCYCL CPDS | 3933 |
13260 | 1 | PYRROLOBENZODIAZEPINE//PYRROLO2 1 C1 4BENZODIAZEPINES//CANC UK GENE TARGETED DRUG DESIGN GRP | 879 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PYRROLOBENZODIAZEPINE | authKW | 2037294 | 8% | 85% | 67 |
2 | PYRROLO2 1 C1 4BENZODIAZEPINES | authKW | 737558 | 3% | 86% | 24 |
3 | CANC UK GENE TARGETED DRUG DESIGN GRP | address | 545352 | 2% | 89% | 17 |
4 | GENE TARGETED DRUG DESIGN GRP | address | 458923 | 2% | 80% | 16 |
5 | PYRROLOBENZODIAZEPINE DIMERS | authKW | 290414 | 1% | 90% | 9 |
6 | SPIROGEN LTD | address | 290414 | 1% | 90% | 9 |
7 | SJG 136 | authKW | 254959 | 1% | 89% | 8 |
8 | GENE TARGETING DRUG DESIGN GRP | address | 184389 | 1% | 86% | 6 |
9 | PYRROLO1 4BENZODIAZEPINES | authKW | 184389 | 1% | 86% | 6 |
10 | CRC GENE TARGETED DRUG DESIGN GRP | address | 179269 | 1% | 100% | 5 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Organic | 14254 | 57% | 0% | 498 |
2 | Chemistry, Medicinal | 3729 | 20% | 0% | 173 |
3 | Pharmacology & Pharmacy | 202 | 11% | 0% | 99 |
4 | Chemistry, Multidisciplinary | 102 | 10% | 0% | 88 |
5 | Microbiology | 67 | 5% | 0% | 45 |
6 | Biotechnology & Applied Microbiology | 41 | 4% | 0% | 39 |
7 | Biochemistry & Molecular Biology | 37 | 10% | 0% | 90 |
8 | Crystallography | 27 | 2% | 0% | 19 |
9 | Chemistry, Applied | 12 | 2% | 0% | 17 |
10 | Oncology | 4 | 4% | 0% | 31 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANC UK GENE TARGETED DRUG DESIGN GRP | 545352 | 2% | 89% | 17 |
2 | GENE TARGETED DRUG DESIGN GRP | 458923 | 2% | 80% | 16 |
3 | SPIROGEN LTD | 290414 | 1% | 90% | 9 |
4 | GENE TARGETING DRUG DESIGN GRP | 184389 | 1% | 86% | 6 |
5 | CRC GENE TARGETED DRUG DESIGN GRP | 179269 | 1% | 100% | 5 |
6 | YORKSHIRE CANC DRUG DESIGN | 138283 | 1% | 43% | 9 |
7 | CR UK DRUG DNA INTERACT GRP | 129069 | 1% | 60% | 6 |
8 | EA IMT 6306 | 107561 | 0% | 100% | 3 |
9 | UATRS ANGLE ALLAL FASSI FAR | 107561 | 0% | 100% | 3 |
10 | CANC UK DRUG DNA INTERACT GRP | 106453 | 2% | 21% | 14 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF HETEROCYCLIC CHEMISTRY | 20516 | 9% | 1% | 80 |
2 | FARMACO-EDIZIONE SCIENTIFICA | 8439 | 2% | 2% | 14 |
3 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 4777 | 7% | 0% | 59 |
4 | FARMACO | 4585 | 2% | 1% | 15 |
5 | TETRAHEDRON LETTERS | 3517 | 10% | 0% | 86 |
6 | HETEROCYCLES | 2692 | 4% | 0% | 32 |
7 | HETEROCYCLIC COMMUNICATIONS | 2184 | 1% | 1% | 10 |
8 | TETRAHEDRON | 2144 | 5% | 0% | 48 |
9 | JOURNAL OF ANTIBIOTICS | 2091 | 2% | 0% | 20 |
10 | JOURNAL OF MEDICINAL CHEMISTRY | 1534 | 4% | 0% | 31 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |